Alkanes, C10-13, chloro

Genetic toxicity: in vitro

Administrative data

Endpoint:

in vitro gene mutation study in mammalian cells

Remarks:

Type of genotoxicity: gene mutation

Type of information:

experimental study

Adequacy of study:

key study

Study period:

no data (study completed 01.12.1987)

Reliability:

2 (reliable with restrictions)

Rationale for reliability incl. deficiencies:

other: According to the final RAR on SCCPs (EU, 2000), this was a well conducted study, "performed to modern protocols".

Data source

Reference

Reference 1

Reference Type:

study report

Title:

Unnamed

Year:

1987

Report date:

1987

Reference 2

Reference Type:

secondary source

Title:

Unnamed

Year:

2000

Materials and methods

Principles of method if other than guideline:

Frequency of mutant colonies assessed in a gene mutation (HPRT) assay.

GLP compliance:

not specified

Type of assay:

mammalian cell gene mutation assay

Test material

Test material information

Constituent 1

Reference substance name:

Alkanes, C10-13, chloro

EC Number:

287-476-5

EC Name:

Alkanes, C10-13, chloro

Cas Number:

85535-84-8

IUPAC Name:

Alkanes, C10-C13, Chloro

Details on test material:

- Name of test material (as cited in study report): Chlorparaffin 56 flϋssig
- Substance type: technical product
- Physical state: no data
- Analytical purity: no data
- Impurities (identity and concentrations): no data
- Composition of test material, percentage of components: C10-13 chlorinated paraffin (56% chlorination)
- Isomers composition: no data
- Purity test date: no data
- Lot/batch No.: no data
- Expiration date of the lot/batch: no data
- Stability under test conditions: no data
- Storage condition of test material: no data

Method

Target gene:

hypoxanthine phosphoribosyltransferase (HPRT)

Species / strain

Species / strain / cell type:

Chinese hamster lung fibroblasts (V79)

Details on mammalian cell type (if applicable):

- Type and identity of media: no data
- Properly maintained: no data
- Periodically checked for Mycoplasma contamination: no data
- Periodically checked for karyotype stability: no data
- Periodically "cleansed" against high spontaneous background: no data

Additional strain / cell type characteristics:

not specified

Metabolic activation:

with and without

Metabolic activation system:

Aroclor-induced rat liver metabolic activation

Test concentrations with justification for top dose:

0, 5, 10, 15, 20 or 30 ug/mL without S9
0, 5, 10, 30, 50 or 75 ug/mL with S9

Vehicle / solvent:

no data

Controls

Untreated negative controls:

not specified

Negative solvent / vehicle controls:

not specified

True negative controls:

not specified

Positive controls:

yes

Positive control substance:

not specified

Details on test system and experimental conditions:

METHOD OF APPLICATION: in medium

DURATION
- Preincubation period: no data
- Exposure duration: no data
- Expression time (cells in growth medium): no data
- Selection time (if incubation with a selection agent): no data
- Fixation time (start of exposure up to fixation or harvest of cells): no data

SELECTION AGENT (mutation assays): 6-thioguanine

NUMBER OF REPLICATIONS: two independent experiments performed

NUMBER OF CELLS EVALUATED: no data

DETERMINATION OF CYTOTOXICITY
- Method: cloning efficiency

Evaluation criteria:

no data

Statistics:

no data

Results and discussion

Test results

Species / strain:

Chinese hamster lung fibroblasts (V79)

Metabolic activation:

with and without

Genotoxicity:

negative

Cytotoxicity / choice of top concentrations:

cytotoxicity

Vehicle controls validity:

not specified

Untreated negative controls validity:

not specified

Positive controls validity:

valid

Additional information on results:

TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: no data
- Effects of osmolality: no data
- Evaporation from medium: no data
- Water solubility: soluble up to 750 ug/mL
- Precipitation: no data



RANGE-FINDING/SCREENING STUDIES: a preliminary study to determine cytotoxicity was conducted to select appropriate dose levels for the main study. The test substance produced a cytotoxic effect from 50 ug/mL with S9 and from 20 ug/mL without S9, up to the limit of solubility (750 ug/mL).


COMPARISON WITH HISTORICAL CONTROL DATA: no data


ADDITIONAL INFORMATION ON CYTOTOXICITY: cytotoxicity was evident at 20 ug/mL and above without S9 and at 50 ug/mL and above with S9

Remarks on result:

other: all strains/cell types tested

Remarks:

Migrated from field 'Test system'.

Applicant's summary and conclusion

Conclusions:

Interpretation of results (migrated information):
negative

In a well-conducted gene mutation (HPRT) study in Chinese hamster V79 cells, Chlorparaffin 56 flϋssig (a C10-13 chlorinated paraffin; 56% chlorination) did not induce a significant, reproducible increase in mutant frequency at doses of up to 75 or 30 ug/mL, with or without a rat liver metabolic activation fraction, respectively.

Executive summary:

Chlorparaffin 56 flϋssig (a C10-13 chlorinated paraffin; 56% chlorination) was assessed for its mutagenic potential in mammalian cells using the HPRT assay. After a preliminary study to determine cytotoxicity of the test substance, it was tested at concentrations of up to 75 or 30 ug/mL with or without a rat liver metabolic activation system (S9), respectively, in cultures of Chinese hamster lung fibroblast (V79) cells. Mutants were selected by their resistance to 6-thioguanine. Two independent experiments were conducted. [According to an expert review (EU, 2000) on SCCPs, the study was well-conducted and carried out to modern protocols.] The test substance did not induce an increase in mutant frequency; cytotoxicity was evident at levels of 50 or 20 ug/mL with or without S9, respectively. In contrast positive control substances (not specified in the available abstract of the report) performed as expected, increasing the mutant frequency, thus demonstrating the validity of the assay. In conclusion, in a gene mutation (HPRT) study in Chinese hamster V79 cells, Chlorparaffin 56 flϋssig did not induce a significant, reproducible increase in mutant frequency at doses of up to 75 or 30 ug/mL with or without S9, respectively.